Advertisement
Advertisement
Xozid

Xozid

febuxostat

Manufacturer:

Globela Pharma

Distributor:

Trumed
Concise Prescribing Info
Contents
Febuxostat
Indications/Uses
Chronic management of hyperuricemia in adult w/ gout in conditions where urate deposition has already occurred (including history or presence of tophus &/or gouty arthritis).
Dosage/Direction for Use
Recommended dose: 40 mg or 80 mg once daily. Patient who does not achieve serum uric acid (sUA) <6 mg/dL after 2 wk 80 mg once daily.
Administration
May be taken with or without food.
Contraindications
Contraindicated in patients being treated w/ azathioprine or mercaptopurine.
Special Precautions
Discontinue of if serious skin reactions are suspected. Not recommended for the treatment of asymptomatic hyperuricemia. CV death. Increase in gout flares after initiation. Measure LFT promptly in patients who report symptoms that may indicate liver injury, including fatigue, anorexia, right upper abdominal discomfort, dark urine or jaundice. Not recommended in patients whom the rate of urate formation is greatly increased (eg, malignant disease, Lesch-Nyhan syndrome). Caution before driving, using machinery or participating in dangerous activities. Caution when administering to breastfeeding women.
Adverse Reactions
Liver function abnormalities; dizziness & diarrhea.
Drug Interactions
May cause increased plasma conc leading to toxicity w/ xanthine oxidase substrate drugs, azathioprine, mercaptopurine & theophylline.
MIMS Class
Hyperuricemia & Gout Preparations
ATC Classification
M04AA03 - febuxostat ; Belongs to the class of preparations inhibiting uric acid production. Used in the treatment of gout.
Presentation/Packing
Form
Xozid FC tab 40 mg
Packing/Price
30's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement